Immunoisolation of hybrid liver support systems by semipermeable membranes

International Journal of Artificial Organs

Volumn 20, Issue 11, 1997, Pages 644-649

  Gleissner M ^a   Bornemann, R ^b   Stemerowicz, R ^b   Meissler M ^b   Neuhaus, P ^b   Gerlach, J C ^b,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bioartificial liver; Hybrid liver support; Immunoisolation; Membranes; Xenogenic antibodies

Indexed keywords

ARTIFICIAL ORGANS; BIOREACTORS; ELECTROPHORESIS; EPITOPES; MEMBRANES;

BIOARTIFICIAL LIVER; CUPROPHAN; HEPATOCYTES; HYBRID LIVER SUPPORT; IMMUNO-ISOLATION; PROTEIN FRACTIONS; SEMI-PERMEABLE MEMBRANES; SIDE EFFECT; SUPPORT SYSTEMS; XENOGENIC ANTIBODY;

ANTIBODIES;

IMMUNOGLOBULIN G ANTIBODY; LIVER ANTIGEN;

ARTICLE; ARTIFICIAL LIVER; ARTIFICIAL ORGAN; HUMAN; IMMUNOBLOTTING; LIVER CELL; MEMBRANE PERMEABILITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SWINE;

EID: 0031449975     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702001108     Document Type: Article

References (31)

1. Gerlach J, Encke J, Hole O, et al. Bioreactor for large scale hepatocyte in-vitro perfusion.Transplantation 1994; 58: 984-8.
2. Rozga J, Podesta L, LePage E, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 219: 538-46.
3. Nyberg SL, Platt JL, Shirabe K, et al. Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J 1992; 38: M463-7.
4. Iwata H, Amemiya H, Matsuda T, et al. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 1989; 38: 224-5
5. Bornemann R, Smith MD, Gerlach JC. Consideration of potential immunological problems in the application of xenogenic hybrid liver support. Int J Artif Organs 1996; 19: 655-63.
6. Takahashi M, Ishikura H, Takahashi C. Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artifical liver. Antiporcine hepatocyte human serum. ASAIO J 1992; 39: M242-6.
7. Schaapherder AF, Daha MR; teBulte MT, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57(9): 1376-82.
8. McKenzie IF, Xing PX, Vaughan HA, et al. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts. Transpl Immunol 1994; 2(2): 81-6.
9. Meyer vom B,schenfelde KH, Miescher PA. Liver specific antigens. Purification and characterization. Clin Exp Immunol 1972; 10: 89-102.
10. Laemli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
11. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76: 4350-6.
12. Schleipfer D. Dialysetechnik. Ein Kompendium über die technischen Grundlagen der Behandlung mit der künstlichen Niere. Schleipfer D, ed. Bionic, Friedrichsdorf 1983.
13. Vierling JM, Immunologic mechanisms of hepatic allograft rejection. Sem Liver Dis 1992; 12: 16-27.
14. Demetris AJ, Murase N, Nakamura K, et al. Immunopathology of antibodies as effectors of orthotopic liver allogaft rejection. Sem Liver Dis 1992; 12: 51-9.
15. Cheung AK, Henderson LW. Effects of complement activation by hemodialysis membranes. Am J Nephrol 1986; 6: 81-91.
16. Kamada N. Animal models of hepatic allograft rejection. Sem Liver Dis 1992; 12: 1-15.
17. Stevens RB, Platt JL. The pathogenesis of hyperacute xenograft rejection. Am J Kidney Dis 1992; 20: 414-21.
18. Casali P, Notkins AL. CD5+ B Lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10: 364-8.
19. Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive antibodies. J Immunol 1994; 153: 3791-803.
20. Parker W, Bruno D, Holzknecht ZE, Platt JL. Characterization and affinity isolation of xenoreactive antibodies. J Immunol 1994: 153: 3791-803.
21. Soares M, Havaux X, VanBeneden R, et al. Characterization of rat anti-Guinea pig circulating xenoreactive natural antibodies and secreting cells. Transplant Proc 1995; 27: 282-5.
22. Platt JL, Holzknecht ZE, Lindman BJ. Porcine endothelial cell antigens recognized by human natural antibodies. Transplant Proc 1994; 26: 1387.
23. Neethling FA, Koren E, Oriol R, et al. Immunoadsorption of natural antibodies from human serum by affinity chromatography using specific carbohydrates protects pig cells from cytotoxic destruction. Transplant Proc 1994; 26: 1378.
24. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-42.
25. McKenzie IF, Xing PX, Vaughan HA, et al. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts. Transpl Immunol 1994; 2(2): 81-6.
26. Karrer FM, Gill R, Ostrowska A, et al. Purified hepatic parenchymal cells are nonimmunogenic in vitro. Transplant Proc 1995; 27: 625-7.
27. Jahn HU. Klinische und experimentelle Studien zur Charakterisierung der Zielantigene von Lebermembranantikrpern. Dissertation, Freie Universität Berlin 1990.
28. Kelly JH, Koussayer T, He D. et al. Assessment of an extracorporeal liver assist device in anhepatic dogs. Artificial Organs 1992; 16: 418-22.
29. Ito Y, Chang TMS. In vitro multicellular hepatocyte spheroids formed in microcapsules. Artificial Organs 1992; 16: 422-7.
30. Gerlach J, Trost T, Ryan CJ, et al. Hybrid liver support system in a short term application on hepatectomized pigs Int J Artif Organs 1994; 17: 549-53.
31. Colagiuri S, Dellit L. Suspected allergy to insulin preparations. Diabetes Care 1988; 11: 365-6.